Skip to main content
. 2022 May 10;53:102331. doi: 10.1016/j.redox.2022.102331

Fig. 4.

Fig. 4

Patient survival rates, as a function of CBS mRNA levels in the primary tumor, in several types of cancer. A-T) Data were obtained from the Atlas database (https://www.proteinatlas.org). ∗p ​< ​0.05, ∗∗p ​< ​0.01, reflect significant differences in patient survival between the high- and low-CBS expressor groups.